N-Glycosidase F; Chryseobacterium meningosepticum; Recombinant; E. coli

Code: 362300-1set D2-231

General description

Note: 1 mU = 1 milliunit.

Recombinant, Chryseobacterium meningosepticum N-Glycosidase F expressed in E. coli. This enzyme from

read more

Your Price
£456.00 EACH
£547.20 inc. VAT

General description

Note: 1 mU = 1 milliunit.

Recombinant, Chryseobacterium meningosepticum N-Glycosidase F expressed in E. coli. This enzyme from Chryseobacterium (formerly Flavobacterium) meningosepticum catalyzes the hydrolysis of N-glycans from high mannose, hybrid and complex glycopeptides, and from glycoproteins generating asparagine-linked oligosaccharides. Supplied with a series of buffers.

Recombinant, Chryseobacterium meningosepticum N-Glycosidase F expressed in E. coli. This enzyme from Chryseobacterium (formerly Flavobacterium) meningosepticum catalyzes the hydrolysis of N-glycans from high mannose, hybrid and complex glycopeptides, and from glycoproteins generating asparagine-linked oligosaccharides.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Fan, J.-Q., and Lee, Y.C. 1997. J. Biol. Chem. 272, 27058.Altmann, F., et al. 1995. Glycoconj. J. 12, 84.

Packaging

1 set in Glass bottle

Physical form

Enzyme supplied in 50 mM NaCl, 20 mM Tris-HCl, 1 mM EDTA, pH 7.5.

Reconstitution

Following initial thaw, aliquot and freeze (-20°C).

Unit Definition

One unit is defined as the amount of enzyme that will completely catalyze the release of N-linked oligosaccharides from 1 µmol denatured ribonuclease in 1 min at 37°C, pH 7.5.

Warning

Toxicity: Standard Handling (A)

foreign activityβ-N-acetylhexosaminidase, α-fucosidase, β-galactosidase, α- and β-mannosidase, proteases, none detected
formliquid
manufacturer/tradenameCalbiochem®
Quality Level100
recombinantexpressed in E. coli
shipped inwet ice
specific activity≥10 units/mg protein
storage conditionavoid repeated freeze/thaw cycles, OK to freeze
storage temp.−20°C
Cas Number83534-39-8
This product has met the following criteria: